Workflow
RL Q3 Earnings Beat, Stock Up on Strong Holiday Result & FY25 View
ZACKS· 2025-02-06 18:51
Ralph Lauren Corporation (RL) posted impressive third-quarter fiscal 2025 results, wherein the top and bottom lines beat the Zacks Consensus Estimate. The third quarter results put an emphasis on better-than-expected holiday sales as the key driver behind higher revenue growth and provide a more optimistic FY25 view.RL reported adjusted earnings per share of $4.82, which surpassed the consensus estimate of $4.48. Also, the bottom line increased 16% from $4.17 per share in the year-earlier quarter.Stay up-to ...
Investors in Kyverna Therapeutics, Inc. Should Contact The Gross Law Firm Before February 7, 2025 to Discuss Your Rights – KYTX
GlobeNewswire· 2025-02-06 18:51
NEW YORK, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Kyverna Therapeutics, Inc. (NASDAQ: KYTX). Shareholders who purchased shares of KYTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/kyverna-therapeutics-inc-loss-submission-form/?id=127303&from=3 CLASS P ...
Class Action Filed Against Pacira BioSciences, Inc. (PCRX) Seeking Recovery for Investors – Contact The Gross Law Firm
GlobeNewswire· 2025-02-06 18:51
NEW YORK, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Pacira BioSciences, Inc. (NASDAQ: PCRX). Shareholders who purchased shares of PCRX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/pacira-biosciences-inc-loss-submission-form/?id=127298&from=3 CLASS PERIO ...
MGP Ingredients, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – MGPI
GlobeNewswire· 2025-02-06 18:50
NEW YORK, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of MGP Ingredients, Inc. (NASDAQ: MGPI). Shareholders who purchased shares of MGPI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/mgp-ingredients-inc-loss-submission-form-2/?id=127292&from=3 CLASS PERIOD: M ...
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Cassava Sciences, Inc. (SAVA) Shareholders
GlobeNewswire· 2025-02-06 18:49
NEW YORK, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Cassava Sciences, Inc. (NASDAQ: SAVA). Shareholders who purchased shares of SAVA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/cassava-sciences-inc-loss-submission-form-2/?id=127299&from=3 CLASS PERIOD: ...
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Regeneron Pharmaceuticals, Inc. (REGN) Shareholders
GlobeNewswire· 2025-02-06 18:48
NEW YORK, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). Shareholders who purchased shares of REGN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/regeneron-pharmaceuticals-inc-loss-submission-form/?id=127300&from ...
Fortinet Stock Is Rallying, But Is It Overbought Before Q4 Earnings?
Benzinga· 2025-02-06 18:46
Fortinet Inc FTNT will be reporting its fourth-quarter earnings on Thursday. Wall Street expects 61 cents in EPS and $1.59 billion in revenues as the company reports after market hours.The stock is up 54.65% over the past year, 10.14% YTD.Let’s look at what the charts indicate for Fortinet stock and how the stock currently maps against Wall Street estimates.Read Also: $100 Invested In Fortinet 15 Years Ago Would Be Worth This Much TodayFortinet Stock Strongly Bullish Ahead Of Q4 EarningsFortinet stock is di ...
Evercore Q4 Earnings & Revenues Beat Estimates, AUM Balance Rises
ZACKS· 2025-02-06 18:46
Evercore Inc.’s (EVR) fourth-quarter 2024 adjusted earnings per share of $3.41 surpassed the Zacks Consensus Estimate of $2.90. Also, the bottom line compared favorably with the prior-year quarter’s $2.02. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Results benefited from an increase in revenues generated from the Investment Management, and Investment Banking & Equities segments.  An improvement in assets under management (AUM) balance was another positive. However, the rise in ...
Corpay Earnings Surpass Estimates in Q4, Revenues Appreciate 10% Y/Y
ZACKS· 2025-02-06 18:46
Corpay (CPAY) reported mixed fourth-quarter 2024 results, wherein earnings surpassed the Zacks Consensus Estimate, while revenues missed the same.See Zacks Earnings Calendar to stay ahead of market-making news.CPAY’s earnings per share of $5.36 beat the consensus estimate by a slight margin and increased 20.7% year over year. The total revenues of $1 billion missed the consensus estimate by 1.5% but grew 10.4% from the year-ago quarter.The stock has gained 35.4% over the past three months compared with the ...
Itau Unibanco Q4 Earnings & Revenues Grow Y/Y, Expenses Increase
ZACKS· 2025-02-06 18:46
Itau Unibanco Holding S.A. (ITUB) reported recurring managerial results of R$10.8 billion ($1.87 billion) for the fourth quarter of 2024, which increased 14.9% year over year.Find the latest earnings estimates and surprises on the Zacks Earnings Calendar.Higher revenues and an increase in managerial financial margin supported the results. Improving credit quality was an added advantage. However, an increase in non-interest expenses acted as a spoilsport.For 2024, the company reported recurring managerial re ...